Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 2/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | HLCS | P50747 | 2/20 | 0.42 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 3/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.35 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.34 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2734736 | 1.00 | ALDH1A1 (0.46) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| SCHEMBL2204763 | 1.00 | ALDH1A1 (0.46) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| SCHEMBL8537115 | 1.00 | ALDH1A1 (0.46) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| SCHEMBL2326236 | 1.00 | ALDH1A1 (0.46) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| SCHEMBL11388793 | 1.00 | ALDH1A1 (0.46) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| Phosphine SCHEMBL28301587 | 0.97 | ALDH1A1 (0.44) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| SCHEMBL2108191 | 0.97 | — | — | |
| SCHEMBL182402 | 0.89 | — | — | |
| SCHEMBL8121418 | 0.86 | CYP1A2 (0.39) | ALDH1A1S1PR3EPHX1TSHRTHRB | |
| SCHEMBL2580848 | 0.84 | ALDH1A1 (0.39) | ALDH1A1S1PR3EPHX1TSHRTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250370170-A1 | TUNABLE LENS WITH FLUID-FILLED CHAMBERS COMPRISING DIFFERENT MATERIALS | APPLE INC (US) | 2025-12-04 | — | — | US | disclosed |
| EP-0825246-A2 | Lubricants and functional fluids containing heterocyclic compounds | The Lubrizol Corporation (US) | 1998-02-25 | — | — | EP | disclosed |
| EP-0825247-A2 | Compositions containing thiocarbonates and acylated-nitrogen containing compounds | The Lubrizol Corporation (US) | 1998-02-25 | — | — | EP | disclosed |
| US-4732668-A | EPITHIO COLLECTORS | THE DOW CHEMICAL COMPANY (US) | 1988-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250370170-A1 | TUNABLE LENS WITH FLUID-FILLED CHAMBERS COMPRISING DIFFERENT MATERIALS | CRYZ, PFAS, CRYAA | ALDH1A1 2580/4885S1PR3 3948/4885EPHX1 1873/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.